within Pharmacolibrary.Drugs.ATC.C;

model C01BC07
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 1.5166666666666666e-06,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0027,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.0022,
    k12             = 0.2,
    k21             = 0.2
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01BC07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Lorcainide is a Class 1c antiarrhythmic agent that was formerly used for the treatment of ventricular arrhythmias. Due to its side effect profile and the development of safer alternatives, lorcainide is not widely used or approved in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>Klotz, U, et al., &amp; Heimburg, P (1978). Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent. <i>Clinical pharmacokinetics</i> 3(5) 407–418. DOI:<a href=&quot;https://doi.org/10.2165/00003088-197803050-00006&quot;>10.2165/00003088-197803050-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/699462/&quot;>https://pubmed.ncbi.nlm.nih.gov/699462</a></p></li><li><p>Mead, RH, et al., &amp; Winkle, RA (1985). Chronic lorcainide therapy for symptomatic premature ventricular complexes: efficacy, pharmacokinetics and evidence for norlorcainide antiarrhythmic effect. <i>The American journal of cardiology</i> 55(1) 72–78. DOI:<a href=&quot;https://doi.org/10.1016/0002-9149(85)90302-9&quot;>10.1016/0002-9149(85)90302-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2578245/&quot;>https://pubmed.ncbi.nlm.nih.gov/2578245</a></p></li><li><p>Eiriksson, Ce, &amp; Brogden, RN (1984). Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. <i>Drugs</i> 27(4) 279–300. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198427040-00001&quot;>10.2165/00003495-198427040-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6373222/&quot;>https://pubmed.ncbi.nlm.nih.gov/6373222</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01BC07;
